Navigation Links
Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves
Date:8/26/2011

than 50 years to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF) and is sold under the brand name Pradaxa®.(8) In the first eight months after approval, nearly 300,000 patients in the U.S. were prescribed PRADAXA.(9)  

"PRADAXA has almost a full year of clinical use for the reduction of stroke risk in patients with non-valvular atrial fibrillation," said Chris Barrett, senior vice president, marketing, Boehringer Ingelheim Pharmaceuticals, Inc. "We continue to see a steady growth in the number of patients treated with PRADAXA and are proud of the widespread formulary coverage that has been achieved, providing access to 90 percent of covered lives in the U.S."

Findings from the Phase III RE-LY® trial showed that PRADAXA 150mg taken twice daily significantly reduced stroke and systemic embolism by 35 percent beyond the reduction achieved with warfarin (dosed to international normalized ratio (INR) 2.0 to 3.0, mean time in therapeutic range = 64.4 percent)(8) in patients with NVAF.(8) Effects of PRADAXA were more apparent in patients with lower levels of INR control.(8)  Dabigatran is recommended in an update to atrial fibrillation treatment guidelines.  

About RE-LY

RE-LY was a global, Phase III, randomized trial of 18,113 patients(8) enrolled in 951 centers in 44 countries,(10) investigating whether dabigatran etexilate (two blinded doses) was as effective as well-controlled warfarin - INR 2.0 - 3.0 - (open label) for stroke prevention.(8)  Patients with non-valvular AFib and at least one other risk factor for stroke (i.e., previous ischemic stroke, transient ischemic attack, or systemic embolism, left ventricular dysfunction, age greater than or equal to 75 years, age greater than or equal to 65 years with either diabetes mellitus, history of coronary artery disease, or hypertension) were enrolled in the study for two years(8) with a minimum fol
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Boehringer Ingelheim and Ashokas Changemakers Launch "Making More Health" Competition
2. Ashoka and Boehringer Ingelheim Announce a Global Partnership for "Making More Health"
3. Zealand Pharma and Boehringer Ingelheim Enter Into a Licence and Collaboration Agreement to Advance Novel Compounds to Treat Type-2 Diabetes and Obesity
4. Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC
5. Positive Phase 2 Results Reported with Boehringer Ingelheims Investigational HCV Protease Inhibitor in Both Previously Treated and Untreated Patients
6. Pfenex Inc. and Boehringer Ingelheim Announce Non-Exclusive Strategic Agreement for the Use of Pfenex Expression Technology™
7. Boehringer Ingelheim to Purchase Amgens Fremont (USA) Facility
8. Boehringer Ingelheim to Purchase Amgens Fremont (California) Facility
9. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
10. Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer
11. Boehringer Ingelheims Pradaxa Available in U.S. Pharmacies Starting Wednesday, November 3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015  Johnson & Johnson (NYSE: ... 10 a.m. (Eastern Time) on Thursday, April 23, 2015, from ... Investors and other interested parties may access ... Company,s website at www.jnj.com and clicking on the ... meeting will be made available a few hours after the ...
(Date:3/27/2015)... , March 27, 2015 Concord ... "Company") (NYSE: CCM ), a leading specialty ... largest network of radiotherapy and diagnostic imaging centers ... the signing of a purchase agreement under which ... owned subsidiary of the Company, agreed to acquire ...
(Date:3/26/2015)... , March 26, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; ... with a focus on Omega-3 therapies for cardiovascular disease ... it issued 763,752 common shares of the Corporation (the ... for the period of December 5 th , 2014 ... Convertible Notes that is due on or before April ...
Breaking Medicine Technology:Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
(Date:3/27/2015)... March 27, 2015 Since September 2014, the ... his comeback tour after having been in retirement for a ... for the performer to return to touring, and concert events ... for Omaha will likely sell out for the two shows ... BuyCheapTicketsToEvents.com to view the inventory of discounted Garth Brooks ...
(Date:3/27/2015)... Irvine, CA (PRWEB) March 27, 2015 ... nation’s leading providers of business support services to dental ... opening of an affiliated Castle Dental office ... Lake Blvd. Hendersonville, TN 37075, this new Castle Dental ... they can receive the latest in comprehensive, quality dental ...
(Date:3/27/2015)... Pastor and Overseer at The House of Yahweh in Abilene, ... through the Laws of Peace written in the Holy Scriptures ... titled, “Yahweh’s Way-The Great Difference” focuses on the past and ... original biblical instructions has caused mass chaos worldwide. ... the world is based on man-made laws that will never ...
(Date:3/27/2015)... The Thomas Scattergood Behavioral Health ... committed to raising its voice to improve the ... The Scattergood Foundation and The Kennedy Forum are ... Practice through the Annual Scattergood Foundation Innovation Award. ... designed to guide the IBS sufferer through 5 ...
(Date:3/26/2015)... Calif. (PRWEB) March 26, 2015 Let’s ... grocery store. Fresh produce are today’s traffic magnets. Three ... particular supermarket because of their produce department, according to ... than ever as people are looking to add more ... Love Your Produce Manager® Day is April 2. As ...
Breaking Medicine News(10 mins):Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2Health News:Castle Dental® Opens Its First Dental Office in Hendersonville, TN 2Health News:Castle Dental® Opens Its First Dental Office in Hendersonville, TN 3Health News:The World Does Not Have to Continue in Misery, Says Yisrayl Hawkins in New Article 2Health News:SoundsLikeIBS Nominated For 3rd Annual Scattergood Innovation Award 2
... June 29 AutismLink, the largest,autism advocacy organization ... Edward G. Rendell and Speaker of the House ... Autism Bill. The Bill, HB1150, is,scheduled for vote ... up,to $36,000 of autism-related treatment for individuals less ...
... Forest University Baptist Medical Center are about to embark ... cancer treatment will be as effective at eradicating cancer ... mice. , The treatment will involve transfusing specific ... patients with advanced forms of cancer. A similar treatment ...
... provide our veterans with the services they need ... dutifully served us., JAMAICA, N.Y., June 28 ... of the Sixth Congressional,District, announced that he will ask ... Capital Asset Realignment for Enhanced Services,(CARES) and its Enhanced ...
... in non-serious side effects , , FRIDAY June 27 (HealthDay ... the marijuana plant don,t increase the risk of serious ... some non-serious side effects, Canadian scientists report. , The ... of British Columbia (UBC) examined adverse events reported in ...
... the leading national program that has certified ... congratulates the Florida House of Representatives and ... new standards for pharmacy technicians. The new ... increasing patient safety for consumers. The legislation ...
... and WHITEHOUSE STATION, N.J., June 27 /PRNewswire-FirstCall/,-- Schering-Plough ... Co., Inc. (NYSE: MRK ),announce the withdrawal ... combination tablet., The companies also terminated the ... May 2000 to develop and,market a fixed-combination product ...
Cached Medicine News:Health News:AutismLink, Autism Center of Pittsburgh Denounce Senate Autism Bill 2Health News:Cancer 'cure' in mice to be tested in humans 2Health News:Cancer 'cure' in mice to be tested in humans 3Health News:Congressman Gregory W. Meeks to Ask for Suspension of CARES Process at the St. Albans Veteran Campus 2Health News:Drugs With Marijuana Compounds Don't Boost Adverse Events 2Health News:Pharmacy Technician Certification Board (PTCB) Supports Florida's New Patient Safety Solution 2Health News:Pharmacy Technician Certification Board (PTCB) Supports Florida's New Patient Safety Solution 3
Adhesive discs sold on rolls of 100, 250, or 1000 each. Manufactured from non-latex medical grade adhesives & material. One size fits all chest pieces....
For accurately monitoring core temperature and heart and breath sounds....
... enables hospitals to standardize ... to a single temperature ... monitoring disposale probes and ... in their manufacture and ...
... Level 1 enables ... multiparameter patient monitors to ... series. Our temperature monitoring ... cables are superior in ...
Medicine Products: